Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation
Conclusion: A protocol based on a single early CMV‐specific T‐cell based assay would offer improved risk‐stratification and individualization of patient management post‐transplant. This could offer improved drug and service utilization and potentially result in significant improvements over both currently used protocols to manage supposedly low‐risk patients. This article is protected by copyright. All rights reserved.
Source: Liver Transplantation - Category: Transplant Surgery Authors: Siddharth Sood, Craig Haifer, Lijia Yu, Julie Pavlovic, Paul J. Gow, Robert M. Jones, Kumar Visvanathan, Peter W. Angus, Adam G. Testro Tags: Original Article Source Type: research
More News: Cytomegalovirus | Liver | Liver Transplant | Study | Testosterone Injection | Transplant Surgery | Transplants | Urology & Nephrology